Baird analyst Peter Benedict lowered the firm’s price target on Petco to $8 from $11 and keeps an Outperform rating on the shares. The firm says that while the company’s Q2 results “were fine,” it has “clearly been on the wrong side recommending WOOF shares.” However, strength in Petco’s services and consumables business, its “aggressive” cost savings plan, and “relatively inexpensive” valuation on EBITDA warrant riding out the category mix pressures “for now,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WOOF:
- Petco Healthcare (NASDAQ: WOOF) Stumbles after Q2 Earnings Drop 62.5%, Future Projections Disappoint
- Petco falls 8% to $6.00 after cutting FY23 EPS guidance
- Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings
- Petco CFO sees shift in consumer spending, pressures on discretionary business
- Petco cuts FY23 adjusted EPS view to 24c-30c from 40c-48c, consensus 42c